[1] |
Feng JW, Ye J, Wu WX, et al. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence[J]. J Endocrinol Invest, 2020, 43(12): 1807-1817.
|
[2] |
Yin Y, Xu X, Shen L, et al. Influencing factors and cumulative risk analysis of cervical lymph node metastasis of papillary thyroid microcarcinoma[J]. Front Oncol, 2021, 11: 644-645.
|
[3] |
Alabousi M, Alabousi A, Adham S, et al. Diagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid cancer cervical lymph node metastasis: A systematic review and Meta-analysis[J]. JAMA Otolaryngol Head Neck Surg, 2021, 12(24): 213-387.
|
[4] |
Zhou SC, Liu TT, Zhou J, et al. An ultrasound radiomics nomogram for preoperative prediction of central neck lymph node metastasis in papillary thyroid carcinoma[J]. Front Oncol, 2020, 10: 1591.
|
[5] |
Patel KN, Yip L, Lubitz CC, et al. The American Association of Endocrine Surgeons Guidelines for the definitive surgical management of thyroid disease in adults[J]. Ann Surg, 2020, 271(3): 21-93.
|
[6] |
Gao M, Ge M, Ji Q, et al. 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma[J]. Cancer Biol Med, 2017, 14(3): 203-211.
|
[7] |
Dismukes J, Fazendin J, Obiarinze R, et al. Prophylactic central neck dissection in papillary thyroid carcinoma: all risks, no reward[J]. J Surg Res, 2021, 264: 230-235.
|
[8] |
Chen L, Wu YH, Lee CH, et al. Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes: A systematic review and Meta-analysis[J]. World J Surg, 2018, 42(9): 2846-2857.
|
[9] |
Ahn JH, Kwak JH, Yoon SG, et al. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma[J]. Surgery, 2022, 171(1): 182-189.
|
[10] |
Su H, Li Y. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: A meta-analysis[J]. Braz J Otorhinolaryngol, 2019, 85(2): 237-243.
|
[11] |
安祥,余丹,李兵. 预防性中央区淋巴结清扫对甲状腺微小乳头状癌患者预后影响的Meta分析[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(2): 138-142.
|
[12] |
Medas F, Canu GL, Cappellacci F, et al. Predictive factors of lymph node metastasis in patients with papillary microcarcinoma of the thyroid: retrospective analysis on 293 cases[J]. Front Endocrinol (Lausanne), 2020, 11: 551.
|
[13] |
Huang J, Sun W, Zhang H, et al. Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis[J]. Clin Endocrinol (Oxf), 2019, 91(1): 170-178.
|
[14] |
Li X, Duan Y, Liu D, et al. Diagnostic model incorporating clinicopathological characteristics of Delphian lymph node metastasis risk profiles in papillary thyroid cancer[J]. Front Endocrinol (Lausanne), 2021, 12: 591015.
|
[15] |
闫云飞,刘娜,叶贝贝, 等. 喉前淋巴结与甲状腺乳头状癌颈部淋巴结转移的相关性研究[J]. 天津医科大学学报, 2021, 27(4): 369-373.
|
[16] |
Isaacs JD, Lundgren C, Sidhu SB, et al. The Delphian lymph node in thyroid cancer[J]. Ann Surg, 2008, 247(3): 477.
|
[17] |
Iyer NG, Kumar A, Nixon IJ, et al. Incidence and significance of Delphian node metastasis in papillary thyroid cancer[J]. Ann Surg, 2011, 253(5): 988-991.
|
[18] |
American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer[J]. Thyroid, 2009, 19(11): 1153-1158.
|
[19] |
Kim Y, Roh JL, Song DE, et al. Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma[J]. Am J Surg, 2020, 220(3): 642-647.
|
[20] |
Isaacs JD, McMullen TP, Sidhu SB, et al. Predictive value of the Delphian and level Ⅵ nodes in papillary thyroid cancer[J]. ANZ J Surg, 2010, 80(11): 834-838.
|
[21] |
Wang B, Wen XZ, Zhang W, et al. Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: A single-institution study, systemic review and meta-analysis[J]. J Otolaryngol Head Neck Surg, 2019, 48(1): 42.
|
[22] |
Kim DH, Kim SW, Hwang SH. Predictive value of Delphian lymph node metastasis in the thyroid cancer[J]. Laryngoscope, 2021, 131(9): 1990-1996.
|
[23] |
Zheng G, Zhang H, Hao S, et al. Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis[J]. Oncotarget, 2017, 8(34): 57089-57098.
|
[24] |
Lan X, Sun W, Zhang H, et al. A Meta-analysis of central lymph node metastasis for predicting lateral involvement in papillary thyroid carcinoma[J]. Otolaryngol Head Neck Surg, 2015, 153: 731-738.
|
[25] |
Tan Z, Ge MH, Zheng CM, et al. The significance of Delphian lymph node in papillary thyroid cancer[J]. Asia Pac J Clin Oncol, 2017, 13: 389-393.
|
[26] |
So YK, Kim MJ, Kim S, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis for prevalence, risk factors, and location[J]. Int J Surg, 2018, 50: 94-103.
|
[27] |
Shaha AR, Migliacci JC, Nixon IJ, et al. Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer[J]. Surgery, 2019, 165(1): 6-11.
|
[28] |
Zhu Y, Lin J, Yan Y, et al. Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer[J]. J Surg Oncol, 2021, 123(7): 1521-1528.
|